PFIZER INC — Director's Dealing 2024

Feb 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2024-02-23

Reporting Person: DAMICO JENNIFER B. (SVP & Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-23	Common Stock	M	9752.0000	$27.3400	Acquired	19228.0000	Direct
2024-02-23	Common Stock	F	451.0000	$27.7600	Disposed	18777.0000	Direct
2024-02-23	Common Stock	F	774.0000	$27.7600	Disposed	18003.0000	Direct
2024-02-23	Common Stock	F	7881.0000	$27.3700	Disposed	10122.0000	Direct
2024-02-24	Common Stock	F	354.0000	$27.7600	Disposed	9768.0000	Direct
2024-02-25	Common Stock	F	1386.0000	$27.7600	Disposed	8382.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-23	Stock Appreciation Rights	$27.3400	M	9752.0000	Disposed	2024-02-23	Common Stock (9752.0000)	Direct

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F6: Price is the closing price of Pfizer common stock on February 23, 2024.